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Available online 30 November 2016Reelin is an extracellularmatrix proteinﬁrst known for its key role in neuronalmigration. Studies in rodent small
intestine suggested that reelin protects the organism from intestinal pathology. Here we determined in mice
colon, by real time-PCR and immunological assays, the expression of the reelin signalling system; its response
to dextran sulphate sodium (DSS) and the response of wild-type and reeler mice to DSS-treatment. DNA meth-
ylationwas determined by bisulﬁtemodiﬁcation and sequencing of genomic DNA. In the colonmucosa reelin ex-
pression is restricted to the myoﬁbroblasts, whereas both epithelial cells and myoﬁbroblasts express reelin
receptors (ApoER2 and VLDLR) and its effector protein Dab1. The muscle layer also expresses reelin. DSS-treat-
ment reduces reelin expression in the muscle but it is activated in the mucosa. Activation of mucosal reelin is
greater inmagnitude and is delayed until after the activation of themyoﬁbroblastsmarker,α-SMA. This indicates
that the DSS-induced reelin up-regulation results from changes in the reelin gene expression rather than from
myoﬁbroblasts proliferation. DSS-treatment does not modify Sp1 or Tbr1 mRNA abundance, but increases that
of TGF-β1 andApoER2, decreases that of CASK andDNMT1and it also decreases the reelin promotermethylation.
Finally, the reeler mice exhibit higher inﬂammatory scores than wild-type mice, indicating that themutation in-
creases the susceptibility to DSS-colitis. In summary, this data are theﬁrst to demonstrate thatmouse distal colon
increases reelin production in response to DSS-colitis via a DNMT1-dependent hypo-methylation of the gene
promoter region and that reelin provides protection against colitis.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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The epithelium of themammalian intestine is a highly differentiated
single cell layer that constitutes both, a physical and functional barrier
between the external environment and the organism. To preserve cellu-
lar integrity and tissue homeostasis, the intestine self-renews every 3 to
6 days by continuous cell renewal originating from stem cells, located at
the crypts, which produce transient amplifying cells. In the colon epi-
thelium the transient amplifying cells give rise to three differentiated
cell types: colonocytes, goblet cells and enteroendocrine cells. These
cell types differentiate while migrating up to the surface epithelium.2, apolipoprotein E receptor 2;
inase; Dab1, Disabled-1; DSS,
)-Methyltransferase 1); IL-1β,
; TGF-β1, transforming growth
ription factor Sp1; Tbr1, T-box
de Farmacia, C/Profesor GarcíaColonocytes have absorptive and secretory functions, goblet cells pro-
duce mucins that protect the mucosa from injury and enteroendocrine
cells secrete hormones that regulate gastrointestinal function. In con-
trast to the small intestine, the colon lacks Paneth cells, has larger crypts
and, instead of villi, it has a rather ﬂattened surface epithelium facing
the lumen [1].
The homeostasis of the intestinal epithelium is based on the balance
between cell proliferation, differentiation and apoptosis. In the embryo
and in the postnatal animal, the regulation of the intestinal epithelium
growth and differentiation depends on bidirectional signals between
the epithelium and mesenchymal cells. This is particularly relevant to
the intestinal myoﬁbroblasts, located immediately subjacent to the
epithelial cells basement membrane. These cells are considered to
orchestrate diverse intestinal events, such as the control of epithelial
turnover, tissue repair, inﬂammation and the immune response. The
myoﬁbroblasts fulﬁll all these functions by expressing and secreting
various extracellular matrix components (cytokines, growth factors, in-
ﬂammatorymediators, adhesion proteins, among others), as well as ex-
pressing receptors for many of these ligands, thereby permitting
bidirectional information ﬂow between the intestinal epithelium and
the extracellular matrix (see [2,3] for reviews).
Table 1
Oligonucleotides sequences used for reverse transcription-polymerase chain reaction assays.
Gene symbol Accession no. Sense (5′-3′) Antisense (5′-3′)
Reelin NM_011261 GGACTAAGAATGCTTATTTCC GGAAGTAGAATTCATCCATCAG
Dab1 NM_010014 GACATCACAGATCATCGG CTGGTACACAGATTGTTCAC
VLDLR NM_013703 GTGTACTTGAAGACCACTGAAGAG GCTGGCTCTGTTACCATTC
ApoER2 NM_053073 GAATGAAGGCAGCCAGAT GTTGTCGAAATTCATGCTC
α-SMA NM_007392 CTTTGCTGGTGATGATGCTA GCGAAGCTCGTTATAGAAGG
IL-1β NM_008361 TTGACGGACCCCAAAAGATG AGAAGGTGCTCATGTCCTCAT
TNF-α NM_013693 TCTCATCAGTTCTATGGCCC GGGAG TAGACAAGGTACAAC
PDGF-BB NM_011057 GCCGGTCCAGGTGAGAAAGATTG GGGGCCGGCGGATTCTCA
TGF-β1 NM_011577 ATCCTGTCCAAACTAAGGCTC TGACCTCTTTAGCATAGTAGTCC
CASK NM_009806 TCTCCAGAAAGTGCTAACGG ATGAAGTGTACCTTGCCTGTG
DNMT1 NM_010066 CAAGTTCTGCCTATCTTGTATCC TGATGTTGAAAGTAAAGGCCTC
Sp1 NM_013672 AACAACTACTACCACCAGCA AACTAGCTGAGGCTGAATAAGGA
Tbr1 NM_009322 CCCTTTCTACCAGTTCTCCT ATATTGTAATGAGCGGTGGG
Oligonucleotides were chosen according to the cDNA sequences entered in GenBank and designed using PerlPrimer program v1.1.14. Dab1, Disabled-1; VLDLR, very low-density lipopro-
tein receptor; ApoER2, apolipoprotein E receptor 2;α-SMA,α-smoothmuscle actin; IL-1β, interleukin-1β; TNF-α, tumornecrosis factorα; PDGF-BB, platelet derived growth factorβ; TGF-
β1, transforming growth factor β1; CASK, calcium/calmodulin-dependent serine protein kinase; DNMT1, (DNA (Cytosine-5-)-Methyltransferase 1); Sp1, transcription factor Sp1; Tbr1,
Tbox, brain1.
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[6] express reelin; its receptors apolipoprotein E receptor 2 (ApoER2)
and very low density lipoprotein receptor (VLDLR), and its effector pro-
tein disabled-1 (Dab1) [4]. Within the mucosa reelin expression is re-
stricted to the myoﬁbroblasts whereas the other proteins are
expressed by both, myoﬁbroblasts and epithelial cells [4–6]. We also
found that the absence of reelin (reelermutation)modiﬁes the small in-
testine morphology and decreases epithelial cell proliferation, migra-
tion and apoptosis, both in the suckling and adult mice [5,7]. Wild
type and reeler mice display a range of aberrant phenotypes including
reduced number of Paneth cells, expanded intercellular space of the
adherens junctions anddesmosomes, and increased gene expression re-
lated to pathological immune response, inﬂammation and tumour de-
velopment. These ﬁndings prompted us to consider that reelin may
have a role in pathological conditions [5,7].
The purpose of the current work was to: i) study the expression of
the reelin signalling system in the colon, ii) test whether the system is
affected by dextran sulphate sodium (DSS)-induced colitis, if so iii)Fig. 1. Reelin and Dab1 mRNA abundance along the mouse intestine. RT-PCR was
performed on total RNA isolated from duodenum, jejunum, ileum, proximal colon and
distal colon of 3 month-old mice. Data were normalized to β-actin. The Dab1 mRNA
levels measured in distal colon were set at 1. The histograms represent the means ±
SEM of arbitrary units of mRNA abundance and are plotted on a logarithmic scale. The
number of animals was 5. One-way Anova showed an effect of intestinal region on Dab1
expression (p b 0.001). Newman–Keuls’ test: #p b 0.001 intestinal region vs. jejunum.investigate the factors involved in the control of reelin expression in
the colon and iv) ﬁnd out whether reelin protects the organism from
the development of colitis by using wild-type and reeler mice.
Preliminary reports of some of these results were published as ab-
stracts [8–10].
2. Materials and methods
2.1. Materials
The antibodies used for immunocytochemistry were: rabbit anti-
reelin G10 from Novus Biologicals Europe, Cambridge, UK; rabbit anti-
reelin (sc5578), rabbit anti-ApoER2 (sc20746) and mouse anti-VLDLR
(sc18824), from Santa Cruz Biotechnology, Inc., Santa Cruz, CA, Dallas,
TX, USA; mouse anti-α-smooth muscle actin (α-SMA) (A5228)
from Sigma-Aldrich, Madrid, Spain; rabbit anti-Dab1 (AB5840)
from Chemicon, Temecula, CA, USA; Biotin-conjugated anti-mouse and
anti-rabbit IgG were obtained from Vector Laboratories Inc. CA, USA;
FITC-conjugated anti-rabbit or anti-mouse IgG from Jackson Immuno
Research Laboratories, Inc. Baltimore, USA and Alexa Fluor 546 anti-
mouse IgG from Thermo Fisher Scientiﬁc, IL, USA. The antibodies
employed for Western Blot assays were: rabbit anti-reelin G10 from
Novus Biologicals; mouse anti-α-SMA (A5228), mouse anti-β-actin
(A5316), mouse anti-GADPH (G8795) and rabbit anti-DNMT1 (DNA
(Cytosine-5-)-Methyltransferase 1) (D4692) from Sigma-Aldrich,
Madrid, Spain. Peroxidase-conjugated anti-mouse and anti-rabbit IgG
were obtained from Sigma-Aldrich, Madrid, Spain. Unless otherwise
stated, the other reagents used in the current study were from Sigma-
Aldrich.
2.2. Animals and experimental conditions
Sixteen day-old, 1 and 3 month-old C57BL/6 mice and 3 month-old
B6C3Fe wild-type and reeler (rl−/rl−) mice were used. Reeler mice
were purchased from Jackson Laboratories through Charles River Labo-
ratories. The animals were housed in a 12:12 light–dark cycle and fed ad
libitum with either a Global rodent diet for C56BL/6 mice or Global
2019 extruded rodent diet for B6C3Fe mice (Harlan Iberica S.L.), with
free access to tap water. Reeler mice were genotyped by
polymerase chain reaction (PCR) analysis of genomic DNA using the
primers (5′-3′) TAATCTGTCCTCACTCTGCC, CAGTTGACATACCTTAAT
and TGCATTAATGTGCAGTGT [11]. The animals were humanely handled
and sacriﬁced by cervical dislocation, in accordance with the European
Council legislation 2010/63/EU concerning the protection of experi-
mental animals.
The dextran sulphate sodium (DSS, MW 40 KDa; TdB Consultancy)
colitis model was employed because it produces many of the events
Fig. 2. Reelin and Dab1 mRNA expression in proximal and distal colon vs. age. 16 day-, 30 day- and 90 day-old mice were used. Data were normalized to β-actin. The Dab1 mRNA levels
measured in thedistal colon of 3month-oldmicewere set at 1.Means±SEMof arbitrary units ofmRNA abundance are plotted vs. age. Thenumber of animals for each agewas 5. One-way
Anova showed an effect of age on reelin expression (p b 0.001). Newman–Keuls' test: *p b 0.001 vs. 16 day-old; #p b 0.001 distal colon vs. proximal colon.
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month-old mice, of similar body weight values, were randomized into
untreated (control) and DSS-treated groups, which received either
water orwater containing 3% (wt/vol) DSS, respectively. Daily, through-
out the DSS-treatment, two observers recorded bodyweight, stool con-
sistency and presence of blood in faeces. A score (scale of 0–3) was
assigned to each of these parameters and the three variables were aver-
aged at each time to calculate the average daily disease activity index
(DAI) as described by Cooper et al. [12]. Animals were sacriﬁced at
day 9 of treatment, the time at which the loss of body weight is about
10% of the initial weight. In some experiments mice were sacriﬁced at
0, 3, 6 or 9 days after initiation of DSS-treatment.
Following sacriﬁce, the murine intestine was removed, opened lon-
gitudinally, washed with ice-cold saline solution and subdivided into
the desired intestinal regions. When required, mucosa and muscle
layer were separated by scraping. The tissues were either ﬁxed in 4%
para-formaldehyde in PBS for histological analysis, frozen at −20 °C
for measurements of myeloperoxidase (MPO) activity or frozen at
−80 °C for RT-PCR and Western assays.
2.3. Isolation of colonocytes and myoﬁbroblasts
Colonocytes andmucosalmyoﬁbroblastswere obtained as previous-
ly described [4]. Brieﬂy, intestinal segments were incubated for 15 min
at room temperature in phosphate-buffered saline (PBS) buffer (inmM:
140 NaCl, 2.7 KCl, 10 phosphate, pH 7.4) (Bioline, #Bio37107) contain-
ing 1 mM dithiothreitol, followed by a 30 min incubation period at
37 °C in PBS buffer containing 1 mM EDTA and 2 mM glucose. After in-
cubation, the tissues were vortexed for 30 s and the loosened
colonocytes were ﬁltered through a 60 nm nylon textile and collected
by centrifugation and resuspended in PBS. For myoﬁbroblasts isolation,
the remaining tissue was rinsed with PBS and incubated for 30min in a
shakingwater bath, at 37 °C, in PBS containing 1mg/ml collagenase and
2 mg/ml hyaluronidase. The tissues were vortexed for 30 s and the
myoﬁbroblasts were pelleted and resuspended in PBS. The isolated
cells were immediately used for immunostaining.
2.4. Relative quantiﬁcation of real-time PCR
Total RNAwas extracted from the indicated tissue using RNeasy® kit
(Qiagen) and sample purity was assessed by spectrophotometricmeasurement of OD260/280. RNA integritywas analysed by visual inspec-
tion after electrophoresis on agarose gel in the presence of ethidium
bromide. cDNA was synthesized from 1 μg of total RNA using
QuantiTect® reverse transcription kit (Qiagen) as described by the
manufacturer. The primers for the genes tested (see Table 1) were cho-
sen according to the mouse cDNA sequences entered in Genbank and
designed using PerlPrimer program v1.1.14 (Parkville, Vic., Australia).
Real-time PCR was performedwith 10 μl Sso Fast™ EvaGreen Supermix
(BioRad), 0.4 μMprimers and 1 μl cDNA. Controlswere carried outwith-
out cDNA. Ampliﬁcation was run in a MiniOpticon™ System (BioRad)
thermal cycler (94 °C/3 min; 35 cycles of 94 °C/40 s, 58 °C/40 s and
72 °C/40 s, and 72 °C/2 min). Following ampliﬁcation, a melting curve
analysis was performed by heating the reactions from 65 to 95 °C in
1 °C intervals while monitoring ﬂuorescence. Analysis conﬁrmed a sin-
gle PCR product at the predicted melting temperature. The PCR primers
efﬁciencies ranged from 90 to 110%. The cycle at which each sample
crossed a ﬂuorescence threshold, Ct, was determined and the triplicate
values for each cDNA were averaged. Analyses of real-time PCR were
done using the comparative Ct method, with the Gene Expression
Macro software supplied by BioRad. β-actin served as reference gene
and was used for samples normalization. The 2−ΔΔC′T method [13] was
used to validate β-actin as internal control gene.2.5. Immunostaining analysis
The cell localization of reelin, Dab1, VLDLR, ApoER2 andα-SMA pro-
teins was performed by immunostaining assays on either intact tissues
or isolated cells as previously described by García-Miranda et al. [4].
When intact tissueswere used, 7 μmthick cryosections of colon samples
were cut and applied to adhesive-coated glass slides. The slides were
washed with PBS, permeabilized with 1% Triton X-100 for 15 min and
washed in PBS for 5 min three times. The sections were blocked with
5% bovine serum albumin (BSA), 3% fetal calf serum (FCS) in PBS for
1 h and incubated overnight at 4 °C with the indicated commercial pri-
mary antibodies. Antibodies were diluted in PBS containing 5% BSA and
3% FCS. Antibody binding was visualized with FITC-conjugated either
anti-rabbit IgG or anti-mouse IgG and with Alexa Fluor 546 anti-
mouse IgG. Nuclei were visualized with Hoechst 33258. The slides
were mounted and photographed with an Olympus BX61 microscope
equipped with an Olympus DP73 camera. Images were acquired and
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Isolated colonocytes andmyoﬁbroblastswere loaded onto adhesive-
coated glass slides, left to dry for 10min at room temperature and ﬁxed
with 2% paraformaldehyde in PBS for 10 min. The slides containing the
isolated cells were washed with PBS, permeabilized with 0.1% Triton X-
100 for 20 min, washed again and incubated with the desired primary
antibody at 4 °C overnight. Antibody binding was visualized with bio-
tinylated secondary antibodies, followed by immunoperoxidase stain-
ing using the Vectastain ABC peroxidase kit (Vector) and 3.3′-
diaminobenzidine. The slides were mounted and photographed with a
Zeiss Axioskop 40 microscope equipped with a SPOT Insight V 3.5.4.1
digital camera (Diagnostic Instrument, Inc.). Acquired images wereFig. 3. Immunolocalization of Reelin, Dab1, VLDLR and ApoER2 in colon. 7 μm distal colon sec
dilution), anti-VLDLR (1:50 dilution), anti-ApoER2 (1:50 dilution) or anti-α-SMA (1:200 dilu
FITC-conjugated anti-mouse IgG or Alexa Fluor 546 anti-mouse IgG (red). Nuclei were visu
obtained from the colon of 90 day-old mice. Isolated colonocytes (C) and myoﬁbroblasts (M)
Dab1 (1:200 dilution), VLDLR (1:25 dilution), ApoER2 (1:25 dilution) or anti-α-SMA (1:100 d
was used as a myoﬁbroblasts marker. Scale bar = 10 μm. Negative controls without primary ananalysed by using Spot Advance 3.5.4.1 Program analysis (Diagnostic In-
strument, Inc).
Controls were carried out without primary antibody.
2.6. Western blot assays
SDS-PAGE was performed on a: i) 4–15% gradient precast polyacryl-
amide gel (BioRad) for reelin, ii) 7.5% polyacrilamide gel for DNMT1 and
iii) 12% polyacrilamide gel for α-SMA. The lysis buffer contained:
150 mM NaCl, 2 mM EDTA, 10 mM EGTA, 1% NP-40, 0.1% sodium
deoxycholate, 1mMphenylmethylsulfonyl ﬂuoride, 20 μg/ml aprotinin,
10 μg/ml leupeptin and 50 mM Tris-HCl, pH 7.5. Protein was extracted
from the desired tissue as described [5]. Brieﬂy, the tissue samplestions (T) were incubated with either anti-reelin G10 (1:100 dilution), anti-Dab1 (1:200
tion) antibodies. Antibody binding was visualized with FITC-conjugated anti-rabbit IgG,
alized with Hoechst. Scale bars represent 50 μm. Colonocytes and myoﬁbroblasts were
were immunostained with antibodies raised either against reelin sc5578 (1:50 dilution),
ilution). Antibody binding was visualized with biotinylated secondary antibodies. α-SMA
tibody were run in parallel. The photographs are representative of three different assays.
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incubated at 4 °C for 10 min on a rotating shaker, followed by centrifu-
gation at 14,000 g for 30 min. The resultant supernatant was dissolved
in the Laemmli sample buffer. A total of 50 μg protein were loaded to
each lane, electrophoresed, electrotransferred onto a nitrocellulose
membrane and the immunoreactive bands were viewed using a chemi-
luminescence procedure (GE Healthcare Select®). Anti-β-actin and
anti-GAPDH antibodies were used to normalize band density values.
Anti-GAPDH was used in the α-SMA Western blot because both pro-
teins have similar MW. The relative abundance of the bands was quan-
tiﬁed using the Image J program version 1.46 (National Institutes for
Health, http://rsb.info.nih.gov/ij/index.html). Protein was measured by
the Bradford method [14] using gamma globulin as the standard.
2.7. Histological assessment of DSS-induced colitis
Histological analysis was performed on 3–4 samples of the distal and
proximal colon of each animal to evaluate the grade of inﬂammation.
5 μm parafﬁn embedded sections of colon were stained with hematox-
ylin-eosin [15] and the histological evaluations were performed in a
blinded fashion by a validated method described by Cooper et al. [12]
with some modiﬁcations. The parameters scored on a 0–3 scale were:
destruction of epithelium and glands, dilatation of glandular crypts, de-
pletion and loss of Goblet cells, inﬁltration of inﬂammatory cells, edema
and crypt abscesses.Fig. 4. Evaluation of the DSS-induced colitis. 3% DSS (dextran sulphate sodium) was administe
index)was assessed daily. The inﬂammatory indicators evaluated at the end of the treatment are
(myeloperoxidase) activity, mRNA relative abundance of IL-1β and TNF-α and representativ
control mice were set at 1. Data are means ± SEM. The number of animals was 10 for each ex
Student’ t-test: *p b 0.001 DSS-treated vs. untreated colon, #p b 0.001 distal vs. proximal colon2.8. Analysis of neutrophil myeloperoxidase activity (MPO)
The enzymeMPO (EC 1.11.1.7) is mostly present in neutrophils and
its tissue activity correlates with the quantity of neutrophil inﬁltration
into the tissue. The MPO assay was performed using the o-dianisidine
dihydrochloride method as described by Krawisz et al. [16]. Brieﬂy,
the proximal and distal colonwere homogenized in a buffer containing:
0.5% hexadecyltrimethylammonium bromide, 0.2 M Tris, pH 6, with an
Ystral polytron homogenizer (position 5, 30 s × 3, 4 °C) and then sub-
jected to ﬁve cycles of freezing and thawing and further disrupted by
three sonications (1 s/10 pulses). The sample was then centrifuged
(7000 xg, 10 min, 4 °C) and the supernatant was used for the MPO
assay. 50 μl of either supernatant or MPO standard were added to
150 μl of reaction buffer containing 0.0005% H2O2, 0.7 mg/ml o-
dianisidine dihydrochloride and 50 mM sodium phosphate. The mix-
turewas incubated at 37 °C for 5min and the absorbancewasmeasured
at 450 nm. One unit of MPO activity was deﬁned as that degrading
1mmol/min ofH2O2. The results are expressed asMPOunits/mgprotein
x min. Protein was determined by the method of Bradford [14].
2.9. Bisulﬁte modiﬁcation and sequencing of genomic DNA
This assay is based on the conversion of non-methylated cytosine to
uracil through bisulﬁte action,whilemethylated cytosine remains unal-
tered. The procedure was performed according to Patterson et al. [17].red in the drinking water during 9 days as described in Methods. The DAI (disease activity
: representative photographs of large intestine and cecum, colonweight/length ratio,MPO
e H&E stained colon sections. The IL-1βmRNA levels measured in the proximal colon of
perimental condition. PC: proximal colon, DC: distal colon, M: mucosa, ML: muscle layer.
. Scale bar = 100 μm.
Fig. 5. DSS-induced colitis and the mRNA abundance of the reelin signalling system. The
proximal and distal colon of 90 day-old mice were used. The histograms represent the
means ± SEM of mRNA abundance fold change produced by DSS-treatment relative to
control mice. Dashed line represents a fold change value of 1. The number of animals
was 10 for each condition. One-way Anova showed an effect of the DSS-treatment on
the colon (p b 0.001). Newman–Keuls' test: ap b 0.001 vs. α-SMA change, bp b 0.001
distal vs. proximal colon. *p b 0.001, #p b 0.05, DSS-treated vs. untreated colon.
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DSS-treated mice using the commercial Kit “DNeasy® Blood and Tis-
sue” (Quiagen) and DNA yield was estimated by optical density mea-
surements (OD260/280). The DNA was bisulﬁte-modiﬁed with a
commercial kit (EZ DNA Methylation™, Zymo Research) and the se-
quence of reelin promoter region, that binds to DNMT1 [18], was
subjected to PCR-ampliﬁcation, using bisulﬁte speciﬁc PCR primers
designed with the Methyl Primer Express Software v.1.0 (Applied
Biosystem, USA) (5′-GTGATAGTGGTTATGTATGATATGTAG-3′ and
5′-ACCTTCTTAAAACCCCTAAC-3´). Ampliﬁcation was run in a
MiniOpticon™ System (BioRad) thermal cycler (95 °C/1 min; 40 cy-
cles of 95 °C/15 s, 61 °C/15 s and 72 °C/30 s, and 72 °C/5 min). The
product was gel-puriﬁed, the DNA extracted with a commercial kit
“QIAquick® Gel Extraction” (Quiagen) and sequenced by the Geno-
mics and Sequencing Service (IBIS, Sevilla, Spain).
2.10. Statistical analysis
Data are presented as mean ± SEM. In the ﬁgures, the vertical bars
that represent the SEM are absent when they are less than symbol
height. Comparisons between different experimental groups were eval-
uated by the two-tailed Student's t-test. One-way ANOVA followed by
the Newman-Keuls' test was used for multiple comparisons (GraphPad
Prism program). Differences were set to be signiﬁcant for p b 0.05.
3. Results
3.1. mRNA levels of reelin and Dab1 in the mice colon
The experimentalworkwas initiated by determining the presence of
reelin and its effector protein Dab1 in the colon and by comparing this
expression with that in the small intestine. The mRNA levels were eval-
uated by real time RT-PCR using total RNA isolated from the small and
large intestine of 3 month-old mice. Fig. 1 shows that the reelin mRNA
levels along the small intestine and colon are of the same order of mag-
nitude whereas those of Dab1 decrease from the proximal to distal in-
testine by approx. two orders of magnitude.
The results in Fig. 2 show that in both, proximal and distal colon the
maximal levels of reelinmRNA are found at 16 days after birth, whereas
no signiﬁcant differences are observed between 1 and 3 months of life.
Dab1 mRNA levels do not change signiﬁcantly with age and, as de-
scribed above, the levels are signiﬁcantly lower in the distal than in
the proximal colon at all the ages tested.
3.2. Reelin, Dab1, VLDLR and ApoER2 protein
The cell location of the reelin-Dab1 signalling system in the mice
colon was determined by immunostaining assays, on intact tissues
and on isolated cells, using antibodies against reelin, Dab1, VLDLR,
ApoER2 and α-SMA. α-SMA was used as a myoﬁbroblasts marker. Fig.
3 reveals that within the mucosa only the cells expressing α-SMA,
namely the myoﬁbroblasts, present a strong reelin-speciﬁc staining.
The speciﬁc signal produced either by the anti-Dab1, the anti-VLDLR
or the anti-ApoER2 antibody is seen in colonocytes and myoﬁbroblasts.
In the isolated colonocytes, the speciﬁc staining of these three proteins
is observed in the cytosol, being particularly strong at the cell apical do-
main. Speciﬁc labelling was not detected in the absence of the corre-
sponding primary antibody
3.3. Reelin-Dab1 signalling system in the colon of control and DSS-treated
mice
To test whether reelin plays a role under inﬂammatory conditions
we determined the effect of colon inﬂammation on the expression of
the reelin signalling system in the colon. DSS-induced inﬂammation
and the evaluation of the inﬂammation indicators were performed asdescribed in the Methods. The results summarized in Fig. 4 reveal that
the DSS-treatment produced signiﬁcant changes in the inﬂammation
indicators tested. As compared to control, the DSS-treated mice present
a signiﬁcant increase in: i) the DAI, the colon weight/length ratio, the
colon myeloperoxidase activity and the mRNA levels of the pro-inﬂam-
matory cytokines IL-1β and TNF-α, ii) a signiﬁcant decrease in the colon
length, iii) a loss of crypt architecture and overall structure of the lamina
propria, iv) amassive inﬁltration ofmixed inﬂammatory cells in themu-
cosa and submucosa, v) mucosal ulceration and vi) muscle layers
thickening.
The effects of DSS-induced colitis on the reelin signalling system
were evaluated by measuring the mRNA levels of reelin, Dab1, VLDLR,
ApoER2 and of the myoﬁbroblasts marker α-SMA in the proximal and
distal colon. The results are given in Fig. 5 as the ratio of themRNA levels
measured in the DSS-treated animals vs. those measured in untreated
mice. They reveal that DSS-treatment signiﬁcantly augments the
mRNA abundance of all the genes under study with the only exception
of VLDLR that does not change during inﬂammation. The DSS-treatment
increases reelinmRNA levels by a factor of 4± 1 (n=10) and of 11± 1
(n=10) in the proximal and distal colon, respectively and these incre-
ments are bigger than those of α-SMA mRNA levels (1.8 ± 0.7, n= 10
and 2.1 ± 0.5, n = 10 in the proximal and distal colon, respectively).
These ﬁndings indicate that DSS-treatment up-regulates the reelin sig-
nalling system. In addition, these results suggest that the reelin up-reg-
ulation results from activation of reelin gene expression rather than
from an increase in the number of cells expressing reelin and α-SMA,
that is of myoﬁbroblasts.
The DSS-induced changes in the markers for inﬂammation and the
mRNA abundance of the genes under study are higher in the distal
than in the proximal colon. Because of these observations, the distal
colon tissue was used in the rest of the experiments described in the
current work.
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To corroborate that the DSS-induced increase in the reelin mRNA
levels is independent of the number of myoﬁbroblasts, we measured
reelin and α-SMA genes expression in the distal colon of mice treated
with 3% DSS in the drinking water during either 0, 3, 6 or 9 days. The
DAI, the histological score of the distal colon and the mRNA levels of
IL-1β and TNF-α were measured to determine colitis development.
Fig. 6 shows that distal colon presents a signiﬁcant increase in inﬂam-
mation after 3 days of treatment that gradually elevates during the
DSS administration. Fig. 6 also indicates that reelin mRNA abundanceFig. 6. Reelin andα-SMAmRNA levels in the distal colon of mice treatedwith DSS during either
are displayed: DAI (disease activity index), histological score of colonmice andmRNA relative ab
0 days were set at 1. The number of animals used in each experimental condition was 9. Otherincreases with the duration of the DSS-treatment, as do IL-1β and
TNF-αmRNA expression. But, α-SMA mRNA reached maximal mRNA
expression levels after three days of DSS-treatment and the increment
is lower than that observed for reelin mRNA abundance.
To determinewhether the DSS-induced increase in reelin gene tran-
scription leads to an increase in reelin protein, we performed Western
blot assays on protein extracted from either intact distal colon, mucosa
or muscle layer of untreated and of 0, 3, 6 and 9 days DSS-treated mice.
The colon of reeler mice was used to verify the speciﬁcity of the anti-
reelin antibody employed andα-SMAprotein abundancewas evaluated
for comparisons. The results (Fig. 7) reveal that themain band detected0, 3, 6 or 9 days. The distal colon of 3month-old mice was used. The following parameters
undance of IL-1β, TNF-α, reelin andα-SMA. The IL-1β and reelinmRNA levelsmeasured at
s details as in Fig. 1. Student's t-test: *p b 0.001, #p b 0.05, DSS-treated vs. untreated colon.
Fig. 7.Western assays of reelin andα-SMA in the distal colon of mice treated with DSS during 0, 3, 6 and 9 days. 50 μg protein from either intact colon, mucosa or muscle layer of control
and DSS-treated 3 month-old mice were loaded in each lane. Protein was also extracted from the intact colon of wild-type and reeler mice. The blots were probed with either anti-reelin
G10 (1:500) or anti-α-SMA (1:10,000) antibodies, as described in theMethods. The blot is representative of three assays. Histograms represent the relative abundance of full-length reelin
and ofα-SMA normalizedwith either anti-β-actin (1:4000) or anti-GADPH (1:15,000), respectively. Values are means± SEM, n=3. One-way Anova showed an effect of the duration of
DSS-treatment on the gene studied (p b 0.001). Newman–Keuls' test: *p b 0.001, 3, 6 or 9 days of treatment vs. 0 days treatment; ap b 0.001, 6 or 9 days vs. 3 days of treatment; bp b 0.001,
9 days vs. 6 days; cp b 0.001, muscle layer vs.mucosa.
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has an apparent molecular mass of approximately 420 kDa, that corre-
sponds to the full-length reelin. Under control conditions (0 days of
treatment), the reelin protein abundance is higher in muscle than in
the mucosa. DSS increases the abundance of full-length reelin in the
mucosa and, as observed with the reelin mRNA levels, the magnitude
of the change increases with the duration of the DSS-treatment. The op-
posite is observed in the muscle layer: the abundance of the reelin pro-
tein decreases with the duration of the DSS-treatment. α-SMA protein
abundance also increases in themucosa of DSS-treatedmice, but the in-
crease is independent of the duration of the treatment and is lower than
that of reelin. Together the observations indicate that the DSS-related
increase in α-SMA happens earlier and is lower than the maximum in-
crease in reelin expression, corroborating the view that the DSS-colitis
activates reelin gene expression.
3.5. DSS-treatment and the control of reelin expression
To explore the mechanism(s) by which colon inﬂammation up-reg-
ulates reelin gene expression, we evaluated the distal colon of control
and DSS-treated mice for: i) the expression of regulators for reelintranscription such as CASK, Sp1 and Tbr1; ii) the expression of the tissue
growth factors TGF-β1 and PDGF-BB reported to affect myoﬁbroblasts
processes and iii) the expression of DNMT1. The results are given in
Fig. 8 and include the ApoER2 mRNA values represented in Fig. 5 as
fold change. It can be seen that DSS-treatment signiﬁcantly: i) increases
the mRNA levels of TGF-β1 and PDGF-BB, ii) decreases those of CASK
and DNMT1 and iii) does not modify those of Sp1. The Western blot
assay of DNMT1 shows that DSS-treatment also reduces DNMT1protein
abundance (Fig. 8B). Trb1mRNA is not detected in themice distal colon
by RT-PCR.
Since DSS-treatment decreases DNMT1 expression, we next deter-
mined whether the reelin up-regulation involves changes in the meth-
ylation of the reelin promoter region. For that wemeasured the bisulﬁte
modiﬁcation of−201 to−400 bp sequence of the reelin promoter re-
gion, as described in Methods. The results (Fig. 9) reveal that the reelin
promoter region examined presents thirty 5´CpG dinucleotides and that
twenty two of them are signiﬁcantly down-methylated by the DSS-
treatment.
These ﬁndings indicate that theDSS-induced decrease inDNMT1ex-
pression leads to hypo-methylation of the reelin gene promoter region
and that other factors might also regulate reelin gene transcription.
Fig. 8. Regulation of reelin gene expression. Distal colon of 3 month-old mice with or without DSS-treatment was used. A, mRNA levels of CASK, Sp1, DNMT1, TGF-β1 and PDGF-BB. The
ApoER2mRNAvalues given in thepresent Figure are those shown as fold change in Fig. 5. The ApoER2mRNA levelsmeasured in controlmicewere set at 1. Thenumber of animalswas 5. B,
Western blot of DNMT1. 50 μg protein extracted from either the untreated or DSS-treated colon were loaded in each lane and the anti-DNMT1 antibody (1:4000) was probed
as described in Materials and methods. The blot is representative of three assays. Histograms represent the relative abundance of DNMT1 normalized with β-actin. Values are
means ± SEM. Student's t-test *p b 0.001, DSS-treated vs. untreated colon.
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To ﬁnd out whether reelin protects the organism from the develop-
ment of colon pathology, such as acute colitis, we compared the re-
sponse of wild-type and reeler mice to DSS-induced colitis. Wild-type
and reeler mice were subjected for 9 days to DSS-treatment. Clinical
and histological characterization of the colon was used to assess colitis
severity, as described in Methods. The results given in the Fig. 10 reveal
that the reeler mice developed a more severe colitis than wild-type
mice, because they exhibit higher: i)mortality during theDSS treatment
(40% vs. 10% in wild-type mice) and ii) inﬂammatory parameters score
(DAI, colonweight/length ratio,MPO activity, IL-1βmRNA level and his-
tological damage). All these results indicate that the reeler mutation in-
creases the susceptibility to DSS-induced inﬂammation.Fig. 9. DSS-treatment and methylation levels of reelin promoter. Genomic DNA was isolated fr
treatment was 9 days. The DNA was treated with sodium bisulﬁte as described in Materials an
promoter region and the DNA extracted was sequenced by the Genomics and Sequence Serv
CpG methylation vs. their position in the reelin promoter region. Values are means ± SEM Stu4. Discussion
Ulcerative colitis is a complex disease in which genetic and environ-
mental factors interact to promote a detrimental immune response in
the gut and imbalance between pro-inﬂammatory and anti-inﬂamma-
tory reactivity. The anti-inﬂammatory reactivity determines whether
the immune response to gut antigens is detrimental or innocuous. Here-
in we show that the reelin signalling system is present in the colon, it is
up-regulated by experimental colitis and it might have an anti-inﬂam-
matory action.
The expression of the reelin signalling system in the mice colon re-
sembles that previously observed in rodent small intestine [4,5] and
human colon [6] in that: i) the mucosal myoﬁbroblasts produce reelin
and ii) as reelin receptors and Dab1 are expressed by both, epithelialom distal colon of either control or 3% DSS-treated 3 month-old mice. The duration of the
d methods. PCR primers were used to amplify the DNMT1 binding sequence of the reelin
ice (IBIS, Seville). Five mice of each condition were used. Results are expressed as % of 5´
dent's t-test: **p b 0.001, *p b 0.01, DSS-treated vs. untreated animals.
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ithelial cells and autocrine actions on the myoﬁbroblasts. There are
some differences between the small and large intestine in the magni-
tude of the reelin-Dab1 expression that might be a consequence of
their homeostatic contribution to the different intestinal regions. Thus,
the age-related changes in reelin-Dab1 expression are much smaller
than those previously observed in rat small intestine [4] and Dab1
mRNA abundance is approx. 100 times greater in the small intestine
than in the distal colon. The latter observation might indicate reelin-in-
dependent actions of Dab1 in the small intestine. The reelin detected in
the muscle layer may correspond to that observed by Böttner et al. [19]
in the enteric nerve plexuses, but they did not detect reelin expression
in the myoﬁbroblasts. They attributed these differences to the anti-
reelin antibody they used.
Since the ﬁrst description of the reelermouse some 60 years ago, the
functions of reelin have been studied intensively in the central nervous
system, but its role in peripheral tissues is not verywell understood. The
current observations reveal that the colon responds to DSS-treatment
by increasing reelin production. The DSS-treatment also increases α-
SMA expression that might result from an increase in the number of
myoﬁbroblasts as found in mice [20] and human [21] colon in response
to IL-1β and TNF-α. Even though DSS-treatment would augment the
number of myoﬁbroblasts, the up-regulation of reelin expression is
higher and temporally delayed when compared to α-SMA. This ﬁnding
indicates that the increment in reelin abundance results from activation
of reelin gene expression rather than from an increase in the number of
myoﬁbroblasts. Altogether, the observations reveal that reelin, though it
is down-regulated after birth, is up-regulated under pathological condi-
tions and could be added to the list of extracellular matrix components
secreted by the myoﬁbroblasts in health and under inﬂammatory con-
ditions. Reports showing up-regulation of reelin following tissue injury
in several organs [22–29] proposed a role for reelin in tissue repair andFig. 10. Evaluation of the DSS- induced inﬂammation in wild-type and reeler mice. 3 mo
microphotographs are representative of 8 different assays performed on 8 reeler and 8 wild-
(p b 0.01). Newman–Keuls' test: *p b 0.01 and **p b 0.05 reeler vs.wild-type mice. Scale bar =our previous observations, revealing reelin involvement in the homeo-
stasis of the small intestine epithelium [5], are consistent with this role.
Several genetic and epigenetic mechanisms regulate reelin gene ex-
pression (see Grayson et al. [30] for a review). The reelin promoter re-
gion contains recognition sites for the transcription factors Sp1 and
Tbr1 [30] and both factors up-regulate reelin expression in brain [31].
Tbr1 requires its association with CASK to activate reelin transcription
in brain [32] and up-regulation of CASK and reelin has been observed
in human esophageal carcinoma [33]. The current data reveal that the
transcriptional control of reelin gene expression in the distal colon dif-
fers from those described in brain and that in esophageal carcinoma.
Thus, neither Tbr1, Sp1 nor CASK seem to mediate the DSS-induced
up-regulation of reelin, because Tbr1 mRNA is undetected in either
control or DSS-treated colon and the DSS-treatment does not modify
Sp1 mRNA abundance and decreases that of CASK. At the present
time we cannot discern whether the decrease in CASK mRNA abun-
dance contributes to reelin up-regulation. Balmaceda et al. [34] re-
ported that ApoER2 down-regulates reelin expression in a human
neuroblastoma cell line but the current study shows that DSS-treat-
ment co-upregulates ApoER2 and reelin. In agreement with
Balmaceda et al. [34], we have shown that reelin down-regulation
is accompanied by an increase in ApoER2 mRNA levels in human
colon adenocarcinoma tissue [6]. These contradictory ﬁndings
might indicate that the cell signalling systems that respond to colitis
challenge differ from those in cancer cells, so that in the former the
global output of the signalling systems is the activation of reelin
transcription whereas in cancer cells the output is the down-regula-
tion of reelin expression.
Reelin expression is also regulated by epigenetic mechanisms such
as methylation and histone deacetylation [30]. Several studies revealed
that histone acetylation/deacetylation and DNA-methylation are con-
nected [30,31,35–39]. The reelin promoter region is embedded in anth-old mice were subjected to 3% DSS in the drinking water for up to 9 days. The
type mice. One-way ANOVA showed an effect of mutation on inﬂammatory parameters
100 μm.
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CpG island is heavily methylated [31,35]. Studies in neural tissues
and in cultured neural cells have shown that reelin transcription in-
creases when DNMT1 gene expression decreases [30]. In agreement
with these observations we found that the DSS-induced reelin up-
regulation is accompanied by: i) decreased abundance of DNMT1
mRNA and protein expression and ii) hypo-methylation of that se-
quence of the reelin promoter region that binds DNMT1 [18]. These
ﬁndings indicate that the DSS-related reduction in the DNMT1 ex-
pression hypo-methylates the reelin gene and hence activates reelin
transcription.
DSS-induced colitis also increases the mRNA levels of the growth
factors TGF-β1. TGF-β1 behaves as an anti-inﬂammatory cytokine
and affects several myoﬁbroblasts processes. These processes in-
clude: i) an increase in α-SMA gene expression in human intestinal
myoﬁbroblasts [40], ii) the differentiation of rat intestine [41] and
lung [42] myoﬁbroblasts and iii) the inhibition of DNMT1 expression
in rat lung myoﬁbroblasts [42]. In accordance with these reports and
our current data, we postulate that TGF-β1 might: i) contribute to
the observed increase inα-SMA expression and ii) up-regulate reelin
synthesis by down-regulating DNMT1. Whether reelin expression,
which accelerates epithelial cell proliferation and migration in the
small intestine [5], contributes to the anti-inﬂammatory action
of TGF-β1 deserves further investigation. The co-upregulation of
reelin and TGF-β1 found in the current study does not agree with re-
ports showing that TGF-β1 down-regulates reelin expression in
esophagous cancer [43]. Again, the up-regulation of a regulatory fac-
tor, in this case TGF-β1, is accompanied by either activation (acute
colitis) or repression (esophagous cancer) of reelin transcription.
As previously stated, the varied expression of TGF-β1 might be due
to differences in cell signalling that may be modiﬁed under different
pathological conditions. In support of this view, there are reports in-
dicating that the reelin gene is hyper-methylated in human colon ad-
enocarcinoma, breast, gastric and pancreatic cancers [6,37–39],
whereas reelin hypo-methylation occurs in response to colitis.
These observations reinforce the role of myoﬁbroblasts in the intes-
tinal physiology and pathology.
Finally, we examined the role of reelin in DSS-induced colon inﬂam-
mation and the results showed that all the inﬂammatory parameters
tested and the mortality are greater in the reeler than in the wild-type
mice. These ﬁndings indicate that themutation aggravates DSS-induced
colitis and corroborates the hypothesis that reelin protects the animal
from colitis development.
In conclusion, the current work reveals that the colon
myoﬁbroblasts express reelin, that DSS-induced colitis activates
reelin expression via DNMT1-dependent hypo-methylation of the
reelin gene promoter region and that reelin protects from DSS-in-
duced colitis development.
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